EHBP1 rs721048: Understanding Prostate Cancer Risk Associations
The genetic variant rs721048 is a single nucleotide polymorphism (SNP) located near the EHBP1 gene. It has been identified through genome-wide association studies as being statistically associated with an increased risk of developing prostate cancer.
What each genotype means
Slightly increased prostate cancer risk
This genotype is associated with a statistically significant, though modest, increase in the risk of developing prostate cancer. Research indicates that the A allele is linked to higher susceptibility across multiple ancestral groups, including Caucasian, African, and Asian populations.
The frequency of this genotype varies significantly by ancestry, reflecting the global distribution of this genetic marker.
Average risk profile
Individuals with this heterozygous genotype do not show the same increased risk profile associated with the homozygous A/A genotype. Current research does not identify this specific combination as a significant factor for prostate cancer susceptibility.
This genotype is observed in various populations, with its prevalence dependent on the underlying frequency of the A and G alleles within specific ancestral groups.
Normal risk profile
This genotype is considered the reference or normal state for this variant. It is not associated with the increased risk of prostate cancer observed in carriers of the A allele.
This is a common genotype found across diverse human populations.
What is rs721048?
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs721048 is located in an intergenic region, meaning it sits in the DNA sequence between genes rather than within a gene that codes for a protein. Specifically, it is often studied in the context of the EHBP1 gene, which is located nearby on chromosome 2. Because it is intergenic, researchers investigate whether this variant might influence the regulation or expression of neighboring genes, potentially affecting biological pathways related to cell growth or hormone signaling. Understanding the location of such variants is a fundamental step in genomics, as it helps scientists map out the non-coding regions of the human genome that may contribute to complex health traits.
The Role of EHBP1
The EHBP1 gene, or EH domain binding protein 1, is the gene most commonly associated with the rs721048 variant in scientific literature. While the exact mechanism by which this variant influences prostate health is still a subject of ongoing research, EHBP1 is known to be involved in intracellular trafficking and endocytosis. These processes are critical for maintaining cellular structure and communication. In the context of prostate tissue, researchers are interested in how variations in or near this gene might alter normal cellular functions. It is important to note that while rs721048 is linked to this region, the variant itself does not change the protein sequence of EHBP1. Instead, it may act as a regulatory marker, potentially influencing how much of the EHBP1 protein is produced or when it is activated within the cells of the prostate gland.
Research and Evidence Strength
The association between rs721048 and prostate cancer has been observed in multiple genome-wide association studies (GWAS). These studies compare the genomes of individuals with prostate cancer to those without the condition to identify common genetic markers. The evidence for this association is generally considered moderate. Meta-analyses, which combine data from many different studies to increase statistical power, have consistently shown a small but statistically significant increase in risk associated with the 'A' allele of rs721048. However, the effect size is relatively modest, meaning that carrying this variant is only one of many factors—including age, family history, and other genetic markers—that contribute to an individual's overall risk. Because prostate cancer is a complex, polygenic condition, no single SNP can be used to predict a diagnosis or determine individual health outcomes.
What You Can Do With This Information
Genetic information regarding variants like rs721048 is primarily used for scientific research and population-level risk stratification rather than individual clinical diagnosis. If you have received results from a genetic test indicating you carry this variant, it is important to understand that this does not constitute a medical diagnosis of prostate cancer. Genetic risk factors are probabilistic, not deterministic. You should never use this information to make decisions about your health or medical care without consulting a qualified healthcare professional. A doctor can provide context based on your personal and family medical history, as well as recommend appropriate screening protocols, such as prostate-specific antigen (PSA) testing, based on established clinical guidelines. Always discuss any concerns about your genetic results with your physician or a certified genetic counselor.
How common is this variant?
The frequency of the rs721048 variant varies significantly across different ancestral populations, with the risk-associated 'A' allele being common in many groups. Global minor allele frequency data indicates that this SNP is widely distributed, though specific percentages depend on the population studied.
Frequently asked questions
Does having the rs721048 variant mean I will get prostate cancer?
No. This variant is only one of many genetic and environmental factors that influence prostate cancer risk. It is not a diagnostic tool, and most people who carry the variant will not develop the disease.
Should I get tested for rs721048?
Routine testing for this specific SNP is not currently recommended by medical organizations for clinical management. If you are concerned about your prostate cancer risk, speak with your doctor about standard screening options based on your age and family history.
Is rs721048 the only genetic marker for prostate cancer?
No, prostate cancer is a complex condition associated with hundreds of different genetic variants. Researchers continue to identify new markers that contribute to the overall genetic risk profile.
Where can I find more information about my genetic risk?
You can discuss your family history and any genetic testing results with a healthcare provider or a board-certified genetic counselor. They can help interpret your results in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs721048?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant (p.Asn843Ser) in the PPIP5K2 gene is associated with hereditary eye disease and altered kinase activity.
This exonic variant in PPIP5K2 is linked to hereditary eye disease and has been shown to reduce phosphatase activity in vitro.
Identified as a pathogenic variant in clinical databases, this SNP contributes to polygenic hazard scores for prostate cancer.
This missense variant (p.Pro384Arg) is associated with familial natural short sleep (FNSS1), an autosomal dominant trait characterized by a reduced need for sleep.
This rare variant in the IFIH1 gene is associated with a protective effect against the development of Type 1 Diabetes.
Recently linked to local adaptation of immune responses in diverse ancestral groups.